No Data
US Stock MarketDetailed Quotes
GNPX Genprex
Watchlist
1.040
+0.106+11.35% Close 06/02 16:00 ET
0.970-0.070-6.73%
Pre 05:07 ET
1.060High0.980Low1.62MVolume
0.990Open0.934Pre Close1.65MTurnover3.18%Turnover RatioLossP/E (TTM)54.06MMarket Cap2.67052wk HighLossP/E (Static)51.98MShares0.72352wk Low2.92P/B53.23MFloat Cap19.450Historical High--Dividend TTM51.18MShs Float0.231Historical Low--Div YieldTTM8.56%Amplitude1.013Avg Price1Lot Size
Pre-Market
- 5D
- 1D
- 1W
- 1M
- 1Q
- 1Y
Company
Genprex, Inc. is a clinical-stage gene therapy company, which engages in the development of therapies for patients with cancer and diabetes. The company’s lead product candidate is REQORSA immunogene therapy drug for non-small cell lung cancer. Its other technologies include GPX-002 gene therapy for diabetes, and ONCOPREX nanoparticle delivery system. Genprex was founded by J. Rodney Varner in April 2009 and is headquartered in Austin, TX.
News
Comments
Read more
money making bean : ??
Robert D Wood : Hmm I think so :)
Deniz Kizilkan :